nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—XDH—Azathioprine—Crohn's disease	0.195	0.376	CbGbCtD
Doxorubicin—XDH—Mercaptopurine—Crohn's disease	0.195	0.376	CbGbCtD
Doxorubicin—ABCC2—Sulfasalazine—Crohn's disease	0.0556	0.107	CbGbCtD
Doxorubicin—ABCG2—Sulfasalazine—Crohn's disease	0.0503	0.0968	CbGbCtD
Doxorubicin—NOS1—myenteric nerve plexus—Crohn's disease	0.0149	0.107	CbGeAlD
Doxorubicin—ABCB1—Prednisone—Crohn's disease	0.0145	0.0279	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—Crohn's disease	0.00868	0.0167	CbGbCtD
Doxorubicin—NOS1—penis—Crohn's disease	0.00843	0.0606	CbGeAlD
Doxorubicin—ABCB11—bile—Crohn's disease	0.0084	0.0604	CbGeAlD
Doxorubicin—NOS3—penis—Crohn's disease	0.00641	0.046	CbGeAlD
Doxorubicin—ABCB8—mouth—Crohn's disease	0.00452	0.0324	CbGeAlD
Doxorubicin—ABCC2—bile—Crohn's disease	0.00427	0.0307	CbGeAlD
Doxorubicin—NDUFS7—mouth—Crohn's disease	0.00305	0.0219	CbGeAlD
Doxorubicin—NDUFS3—mouth—Crohn's disease	0.0025	0.0179	CbGeAlD
Doxorubicin—CBR3—mammalian vulva—Crohn's disease	0.00219	0.0158	CbGeAlD
Doxorubicin—AKR1A1—smooth muscle tissue—Crohn's disease	0.00188	0.0135	CbGeAlD
Doxorubicin—AKR1A1—skin of body—Crohn's disease	0.00186	0.0133	CbGeAlD
Doxorubicin—AKR1A1—mammalian vulva—Crohn's disease	0.00169	0.0122	CbGeAlD
Doxorubicin—NQO1—gall bladder—Crohn's disease	0.00165	0.0119	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—Crohn's disease	0.0015	0.0108	CbGeAlD
Doxorubicin—AKR1A1—digestive system—Crohn's disease	0.00149	0.0107	CbGeAlD
Doxorubicin—ABCC3—gall bladder—Crohn's disease	0.00148	0.0107	CbGeAlD
Doxorubicin—NOS1—epithelium—Crohn's disease	0.00148	0.0106	CbGeAlD
Doxorubicin—NQO1—mouth—Crohn's disease	0.00147	0.0106	CbGeAlD
Doxorubicin—AURKA—mammalian vulva—Crohn's disease	0.00143	0.0103	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—Crohn's disease	0.00143	0.0102	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—Crohn's disease	0.00142	0.0102	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—Crohn's disease	0.0014	0.0101	CbGeAlD
Doxorubicin—NDUFS2—skin of body—Crohn's disease	0.0014	0.01	CbGeAlD
Doxorubicin—NDUFS3—skin of body—Crohn's disease	0.00138	0.00992	CbGeAlD
Doxorubicin—NDUFS7—digestive system—Crohn's disease	0.00135	0.0097	CbGeAlD
Doxorubicin—DHCR7—skin of body—Crohn's disease	0.00131	0.00943	CbGeAlD
Doxorubicin—NDUFS2—mammalian vulva—Crohn's disease	0.00128	0.00916	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—Crohn's disease	0.00127	0.00913	CbGeAlD
Doxorubicin—NDUFS3—mammalian vulva—Crohn's disease	0.00126	0.00905	CbGeAlD
Doxorubicin—AURKA—digestive system—Crohn's disease	0.00125	0.00902	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—Crohn's disease	0.00122	0.00877	CbGeAlD
Doxorubicin—DHCR7—mammalian vulva—Crohn's disease	0.0012	0.0086	CbGeAlD
Doxorubicin—ABCB8—lymph node—Crohn's disease	0.00114	0.0082	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—Crohn's disease	0.00113	0.00814	CbGeAlD
Doxorubicin—NOS1—digestive system—Crohn's disease	0.00113	0.00809	CbGeAlD
Doxorubicin—NOS3—epithelium—Crohn's disease	0.00112	0.00808	CbGeAlD
Doxorubicin—NDUFS2—digestive system—Crohn's disease	0.00112	0.00804	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—Crohn's disease	0.00112	0.00804	CbGeAlD
Doxorubicin—NDUFS3—digestive system—Crohn's disease	0.0011	0.00794	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—Crohn's disease	0.0011	0.00792	CbGeAlD
Doxorubicin—CBR3—lymph node—Crohn's disease	0.0011	0.00789	CbGeAlD
Doxorubicin—YWHAG—mammalian vulva—Crohn's disease	0.0011	0.00789	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—Crohn's disease	0.00108	0.00779	CbGeAlD
Doxorubicin—XDH—mammalian vulva—Crohn's disease	0.00107	0.0077	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—Crohn's disease	0.00106	0.00764	CbGeAlD
Doxorubicin—DHCR7—digestive system—Crohn's disease	0.00105	0.00754	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—Crohn's disease	0.00102	0.0073	CbGeAlD
Doxorubicin—CBR1—skin of body—Crohn's disease	0.00102	0.00729	CbGeAlD
Doxorubicin—RALBP1—mammalian vulva—Crohn's disease	0.000992	0.00713	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—Crohn's disease	0.000975	0.00701	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Prednisone—Crohn's disease	0.000968	0.294	CbGdCrCtD
Doxorubicin—YWHAG—digestive system—Crohn's disease	0.000963	0.00692	CbGeAlD
Doxorubicin—XDH—digestive system—Crohn's disease	0.000939	0.00675	CbGeAlD
Doxorubicin—CBR1—mammalian vulva—Crohn's disease	0.000926	0.00665	CbGeAlD
Doxorubicin—ABCB11—digestive system—Crohn's disease	0.000918	0.00659	CbGeAlD
Doxorubicin—AKR1C3—mammalian vulva—Crohn's disease	0.000914	0.00657	CbGeAlD
Doxorubicin—RALBP1—digestive system—Crohn's disease	0.00087	0.00625	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—Crohn's disease	0.000866	0.00622	CbGeAlD
Doxorubicin—NOS3—digestive system—Crohn's disease	0.000856	0.00615	CbGeAlD
Doxorubicin—NQO1—epithelium—Crohn's disease	0.000855	0.00614	CbGeAlD
Doxorubicin—AKR1A1—lymph node—Crohn's disease	0.000848	0.0061	CbGeAlD
Doxorubicin—POR—mammalian vulva—Crohn's disease	0.000835	0.006	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—Crohn's disease	0.000824	0.00592	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—Crohn's disease	0.000822	0.00591	CbGeAlD
Doxorubicin—NQO1—skin of body—Crohn's disease	0.000813	0.00584	CbGeAlD
Doxorubicin—CBR1—digestive system—Crohn's disease	0.000812	0.00583	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Prednisone—Crohn's disease	0.0008	0.243	CbGdCrCtD
Doxorubicin—TOP2A—mammalian vulva—Crohn's disease	0.000778	0.00559	CbGeAlD
Doxorubicin—NDUFS7—lymph node—Crohn's disease	0.000771	0.00554	CbGeAlD
Doxorubicin—NQO1—mammalian vulva—Crohn's disease	0.000742	0.00533	CbGeAlD
Doxorubicin—AURKA—lymph node—Crohn's disease	0.000717	0.00515	CbGeAlD
Doxorubicin—ABCC10—mammalian vulva—Crohn's disease	0.000663	0.00476	CbGeAlD
Doxorubicin—NQO1—digestive system—Crohn's disease	0.000651	0.00467	CbGeAlD
Doxorubicin—NDUFS2—lymph node—Crohn's disease	0.000639	0.00459	CbGeAlD
Doxorubicin—NDUFS3—lymph node—Crohn's disease	0.000631	0.00453	CbGeAlD
Doxorubicin—DHCR7—lymph node—Crohn's disease	0.0006	0.00431	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—Crohn's disease	0.000588	0.00423	CbGeAlD
Doxorubicin—ABCC3—digestive system—Crohn's disease	0.000584	0.0042	CbGeAlD
Doxorubicin—ABCC10—digestive system—Crohn's disease	0.000581	0.00418	CbGeAlD
Doxorubicin—CYP1B1—smooth muscle tissue—Crohn's disease	0.000579	0.00416	CbGeAlD
Doxorubicin—CYP1B1—skin of body—Crohn's disease	0.000571	0.0041	CbGeAlD
Doxorubicin—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.000563	0.171	CbGdCrCtD
Doxorubicin—YWHAG—lymph node—Crohn's disease	0.00055	0.00395	CbGeAlD
Doxorubicin—RALBP1—lymph node—Crohn's disease	0.000497	0.00357	CbGeAlD
Doxorubicin—NOS3—lymph node—Crohn's disease	0.000489	0.00351	CbGeAlD
Doxorubicin—ABCC1—mammalian vulva—Crohn's disease	0.000469	0.00337	CbGeAlD
Doxorubicin—ABCC2—digestive system—Crohn's disease	0.000467	0.00335	CbGeAlD
Doxorubicin—CBR1—lymph node—Crohn's disease	0.000464	0.00333	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—Crohn's disease	0.000463	0.00332	CbGeAlD
Doxorubicin—AKR1C3—lymph node—Crohn's disease	0.000458	0.00329	CbGeAlD
Doxorubicin—CYP1B1—digestive system—Crohn's disease	0.000457	0.00328	CbGeAlD
Doxorubicin—POR—lymph node—Crohn's disease	0.000418	0.00301	CbGeAlD
Doxorubicin—CBR3—Betamethasone—Prednisone—Crohn's disease	0.000396	0.12	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—Crohn's disease	0.000396	0.12	CbGdCrCtD
Doxorubicin—CYP2B6—skin of body—Crohn's disease	0.000392	0.00282	CbGeAlD
Doxorubicin—TOP2A—lymph node—Crohn's disease	0.00039	0.0028	CbGeAlD
Doxorubicin—ABCG2—mammalian vulva—Crohn's disease	0.000388	0.00279	CbGeAlD
Doxorubicin—NQO1—lymph node—Crohn's disease	0.000372	0.00267	CbGeAlD
Doxorubicin—ABCC3—lymph node—Crohn's disease	0.000334	0.0024	CbGeAlD
Doxorubicin—ABCC10—lymph node—Crohn's disease	0.000332	0.00238	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—Crohn's disease	0.000318	0.00228	CbGeAlD
Doxorubicin—CYP2B6—digestive system—Crohn's disease	0.000314	0.00226	CbGeAlD
Doxorubicin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000307	0.00152	CcSEcCtD
Doxorubicin—Bronchitis—Mesalazine—Crohn's disease	0.000304	0.0015	CcSEcCtD
Doxorubicin—Amenorrhoea—Prednisone—Crohn's disease	0.000304	0.0015	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000302	0.00149	CcSEcCtD
Doxorubicin—Pancytopenia—Mesalazine—Crohn's disease	0.000301	0.00149	CcSEcCtD
Doxorubicin—Neutropenia—Mesalazine—Crohn's disease	0.000296	0.00146	CcSEcCtD
Doxorubicin—Dysuria—Mesalazine—Crohn's disease	0.000296	0.00146	CcSEcCtD
Doxorubicin—Viral infection—Prednisone—Crohn's disease	0.000295	0.00146	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000294	0.00145	CcSEcCtD
Doxorubicin—Arthropathy—Prednisone—Crohn's disease	0.000293	0.00145	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000293	0.00145	CcSEcCtD
Doxorubicin—Pollakiuria—Mesalazine—Crohn's disease	0.000292	0.00145	CcSEcCtD
Doxorubicin—Agranulocytosis—Azathioprine—Crohn's disease	0.000289	0.00143	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000289	0.00143	CcSEcCtD
Doxorubicin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000288	0.00143	CcSEcCtD
Doxorubicin—Weight increased—Mesalazine—Crohn's disease	0.000288	0.00142	CcSEcCtD
Doxorubicin—Weight decreased—Mesalazine—Crohn's disease	0.000286	0.00142	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000286	0.00142	CcSEcCtD
Doxorubicin—Pneumonia—Mesalazine—Crohn's disease	0.000284	0.0014	CcSEcCtD
Doxorubicin—Infestation NOS—Mesalazine—Crohn's disease	0.000282	0.0014	CcSEcCtD
Doxorubicin—Infestation—Mesalazine—Crohn's disease	0.000282	0.0014	CcSEcCtD
Doxorubicin—Ulcer—Prednisone—Crohn's disease	0.000282	0.0014	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00028	0.00138	CcSEcCtD
Doxorubicin—Haemoglobin—Azathioprine—Crohn's disease	0.000279	0.00138	CcSEcCtD
Doxorubicin—Haemorrhage—Azathioprine—Crohn's disease	0.000278	0.00138	CcSEcCtD
Doxorubicin—Renal failure—Mesalazine—Crohn's disease	0.000277	0.00137	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000277	0.00137	CcSEcCtD
Doxorubicin—Jaundice—Mesalazine—Crohn's disease	0.000275	0.00136	CcSEcCtD
Doxorubicin—Stomatitis—Mesalazine—Crohn's disease	0.000275	0.00136	CcSEcCtD
Doxorubicin—Conjunctivitis—Mesalazine—Crohn's disease	0.000274	0.00136	CcSEcCtD
Doxorubicin—Urinary tract infection—Mesalazine—Crohn's disease	0.000274	0.00136	CcSEcCtD
Doxorubicin—Sweating—Mesalazine—Crohn's disease	0.000271	0.00134	CcSEcCtD
Doxorubicin—Haematuria—Mesalazine—Crohn's disease	0.000269	0.00133	CcSEcCtD
Doxorubicin—Hiccups—Prednisone—Crohn's disease	0.000267	0.00132	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000267	0.00132	CcSEcCtD
Doxorubicin—ABCC2—lymph node—Crohn's disease	0.000267	0.00191	CbGeAlD
Doxorubicin—Epistaxis—Mesalazine—Crohn's disease	0.000266	0.00132	CcSEcCtD
Doxorubicin—Sinusitis—Mesalazine—Crohn's disease	0.000265	0.00131	CcSEcCtD
Doxorubicin—Agranulocytosis—Mesalazine—Crohn's disease	0.000263	0.0013	CcSEcCtD
Doxorubicin—Erythema multiforme—Azathioprine—Crohn's disease	0.000263	0.0013	CcSEcCtD
Doxorubicin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000262	0.0013	CcSEcCtD
Doxorubicin—CYP1B1—lymph node—Crohn's disease	0.000261	0.00188	CbGeAlD
Doxorubicin—Skin exfoliation—Prednisone—Crohn's disease	0.000255	0.00126	CcSEcCtD
Doxorubicin—Haemoglobin—Mesalazine—Crohn's disease	0.000255	0.00126	CcSEcCtD
Doxorubicin—Rhinitis—Mesalazine—Crohn's disease	0.000254	0.00126	CcSEcCtD
Doxorubicin—Fluid retention—Prednisone—Crohn's disease	0.000253	0.00125	CcSEcCtD
Doxorubicin—Haemorrhage—Mesalazine—Crohn's disease	0.000253	0.00125	CcSEcCtD
Doxorubicin—Hepatitis—Mesalazine—Crohn's disease	0.000253	0.00125	CcSEcCtD
Doxorubicin—Pharyngitis—Mesalazine—Crohn's disease	0.000251	0.00124	CcSEcCtD
Doxorubicin—Immune system disorder—Azathioprine—Crohn's disease	0.000251	0.00124	CcSEcCtD
Doxorubicin—Mediastinal disorder—Azathioprine—Crohn's disease	0.000251	0.00124	CcSEcCtD
Doxorubicin—Neuropathy—Prednisone—Crohn's disease	0.000251	0.00124	CcSEcCtD
Doxorubicin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00025	0.00124	CcSEcCtD
Doxorubicin—Oedema peripheral—Mesalazine—Crohn's disease	0.00025	0.00123	CcSEcCtD
Doxorubicin—Chills—Azathioprine—Crohn's disease	0.00025	0.00123	CcSEcCtD
Doxorubicin—Connective tissue disorder—Mesalazine—Crohn's disease	0.000249	0.00123	CcSEcCtD
Doxorubicin—Arrhythmia—Azathioprine—Crohn's disease	0.000248	0.00123	CcSEcCtD
Doxorubicin—Urethral disorder—Mesalazine—Crohn's disease	0.000248	0.00123	CcSEcCtD
Doxorubicin—Alopecia—Azathioprine—Crohn's disease	0.000246	0.00122	CcSEcCtD
Doxorubicin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000244	0.00121	CcSEcCtD
Doxorubicin—Oesophagitis—Prednisone—Crohn's disease	0.000244	0.00121	CcSEcCtD
Doxorubicin—Ecchymosis—Prednisone—Crohn's disease	0.000241	0.00119	CcSEcCtD
Doxorubicin—Erythema multiforme—Mesalazine—Crohn's disease	0.000239	0.00118	CcSEcCtD
Doxorubicin—Pulmonary oedema—Prednisone—Crohn's disease	0.000238	0.00117	CcSEcCtD
Doxorubicin—CYP3A4—digestive system—Crohn's disease	0.000237	0.0017	CbGeAlD
Doxorubicin—Eye disorder—Mesalazine—Crohn's disease	0.000237	0.00117	CcSEcCtD
Doxorubicin—Tinnitus—Mesalazine—Crohn's disease	0.000236	0.00117	CcSEcCtD
Doxorubicin—Cardiac disorder—Mesalazine—Crohn's disease	0.000235	0.00116	CcSEcCtD
Doxorubicin—ABCC1—lymph node—Crohn's disease	0.000235	0.00169	CbGeAlD
Doxorubicin—CYP2D6—digestive system—Crohn's disease	0.000233	0.00168	CbGeAlD
Doxorubicin—Sepsis—Prednisone—Crohn's disease	0.000232	0.00115	CcSEcCtD
Doxorubicin—Angiopathy—Mesalazine—Crohn's disease	0.00023	0.00114	CcSEcCtD
Doxorubicin—Immune system disorder—Mesalazine—Crohn's disease	0.000229	0.00113	CcSEcCtD
Doxorubicin—Mediastinal disorder—Mesalazine—Crohn's disease	0.000228	0.00113	CcSEcCtD
Doxorubicin—Chills—Mesalazine—Crohn's disease	0.000227	0.00112	CcSEcCtD
Doxorubicin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000227	0.00112	CcSEcCtD
Doxorubicin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000225	0.00111	CcSEcCtD
Doxorubicin—Alopecia—Mesalazine—Crohn's disease	0.000224	0.00111	CcSEcCtD
Doxorubicin—Thrombophlebitis—Prednisone—Crohn's disease	0.000224	0.00111	CcSEcCtD
Doxorubicin—Anaemia—Azathioprine—Crohn's disease	0.000224	0.00111	CcSEcCtD
Doxorubicin—Diabetes mellitus—Prednisone—Crohn's disease	0.000223	0.0011	CcSEcCtD
Doxorubicin—Mental disorder—Mesalazine—Crohn's disease	0.000222	0.0011	CcSEcCtD
Doxorubicin—ABCB1—epithelium—Crohn's disease	0.000221	0.00158	CbGeAlD
Doxorubicin—Erythema—Mesalazine—Crohn's disease	0.00022	0.00109	CcSEcCtD
Doxorubicin—Malaise—Azathioprine—Crohn's disease	0.000218	0.00108	CcSEcCtD
Doxorubicin—Flatulence—Mesalazine—Crohn's disease	0.000217	0.00107	CcSEcCtD
Doxorubicin—Leukopenia—Azathioprine—Crohn's disease	0.000217	0.00107	CcSEcCtD
Doxorubicin—Vascular purpura—Prednisone—Crohn's disease	0.000217	0.00107	CcSEcCtD
Doxorubicin—Tension—Mesalazine—Crohn's disease	0.000216	0.00107	CcSEcCtD
Doxorubicin—Dysgeusia—Mesalazine—Crohn's disease	0.000216	0.00107	CcSEcCtD
Doxorubicin—Nervousness—Mesalazine—Crohn's disease	0.000214	0.00106	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Prednisone—Crohn's disease	0.000214	0.00106	CcSEcCtD
Doxorubicin—Back pain—Mesalazine—Crohn's disease	0.000213	0.00105	CcSEcCtD
Doxorubicin—Muscle spasms—Mesalazine—Crohn's disease	0.000212	0.00105	CcSEcCtD
Doxorubicin—Vomiting—Mercaptopurine—Crohn's disease	0.000211	0.00104	CcSEcCtD
Doxorubicin—Rash—Mercaptopurine—Crohn's disease	0.000209	0.00103	CcSEcCtD
Doxorubicin—Dermatitis—Mercaptopurine—Crohn's disease	0.000209	0.00103	CcSEcCtD
Doxorubicin—Vision blurred—Mesalazine—Crohn's disease	0.000208	0.00103	CcSEcCtD
Doxorubicin—Increased appetite—Prednisone—Crohn's disease	0.000206	0.00102	CcSEcCtD
Doxorubicin—Arthralgia—Azathioprine—Crohn's disease	0.000206	0.00102	CcSEcCtD
Doxorubicin—Myalgia—Azathioprine—Crohn's disease	0.000206	0.00102	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000205	0.00101	CcSEcCtD
Doxorubicin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000205	0.00101	CcSEcCtD
Doxorubicin—Anaemia—Mesalazine—Crohn's disease	0.000204	0.00101	CcSEcCtD
Doxorubicin—Discomfort—Azathioprine—Crohn's disease	0.000204	0.00101	CcSEcCtD
Doxorubicin—Purpura—Prednisone—Crohn's disease	0.000201	0.000994	CcSEcCtD
Doxorubicin—Malaise—Mesalazine—Crohn's disease	0.000199	0.000983	CcSEcCtD
Doxorubicin—Cardiac failure—Prednisone—Crohn's disease	0.000199	0.000982	CcSEcCtD
Doxorubicin—Vertigo—Mesalazine—Crohn's disease	0.000198	0.00098	CcSEcCtD
Doxorubicin—Syncope—Mesalazine—Crohn's disease	0.000198	0.000978	CcSEcCtD
Doxorubicin—Lethargy—Prednisone—Crohn's disease	0.000198	0.000978	CcSEcCtD
Doxorubicin—Leukopenia—Mesalazine—Crohn's disease	0.000197	0.000976	CcSEcCtD
Doxorubicin—Nausea—Mercaptopurine—Crohn's disease	0.000197	0.000974	CcSEcCtD
Doxorubicin—Infection—Azathioprine—Crohn's disease	0.000196	0.000971	CcSEcCtD
Doxorubicin—Palpitations—Mesalazine—Crohn's disease	0.000195	0.000964	CcSEcCtD
Doxorubicin—ABCG2—lymph node—Crohn's disease	0.000194	0.0014	CbGeAlD
Doxorubicin—Loss of consciousness—Mesalazine—Crohn's disease	0.000194	0.000958	CcSEcCtD
Doxorubicin—Osteoarthritis—Prednisone—Crohn's disease	0.000194	0.000958	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000194	0.000958	CcSEcCtD
Doxorubicin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000193	0.000957	CcSEcCtD
Doxorubicin—Cough—Mesalazine—Crohn's disease	0.000192	0.000951	CcSEcCtD
Doxorubicin—Skin disorder—Azathioprine—Crohn's disease	0.000192	0.000949	CcSEcCtD
Doxorubicin—ABCB1—mammalian vulva—Crohn's disease	0.000191	0.00137	CbGeAlD
Doxorubicin—Affect lability—Prednisone—Crohn's disease	0.000191	0.000943	CcSEcCtD
Doxorubicin—Hypertension—Mesalazine—Crohn's disease	0.00019	0.000941	CcSEcCtD
Doxorubicin—Myalgia—Mesalazine—Crohn's disease	0.000188	0.000928	CcSEcCtD
Doxorubicin—Arthralgia—Mesalazine—Crohn's disease	0.000188	0.000928	CcSEcCtD
Doxorubicin—Chest pain—Mesalazine—Crohn's disease	0.000188	0.000928	CcSEcCtD
Doxorubicin—Anxiety—Mesalazine—Crohn's disease	0.000187	0.000925	CcSEcCtD
Doxorubicin—Face oedema—Prednisone—Crohn's disease	0.000187	0.000925	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000186	0.000922	CcSEcCtD
Doxorubicin—Discomfort—Mesalazine—Crohn's disease	0.000185	0.000917	CcSEcCtD
Doxorubicin—Hypotension—Azathioprine—Crohn's disease	0.000185	0.000913	CcSEcCtD
Doxorubicin—Cardiac arrest—Prednisone—Crohn's disease	0.000184	0.000911	CcSEcCtD
Doxorubicin—Dry mouth—Mesalazine—Crohn's disease	0.000184	0.000908	CcSEcCtD
Doxorubicin—Mood swings—Prednisone—Crohn's disease	0.000184	0.000907	CcSEcCtD
Doxorubicin—Confusional state—Mesalazine—Crohn's disease	0.000181	0.000897	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00018	0.00089	CcSEcCtD
Doxorubicin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00018	0.00089	CcSEcCtD
Doxorubicin—Oedema—Mesalazine—Crohn's disease	0.00018	0.00089	CcSEcCtD
Doxorubicin—Infection—Mesalazine—Crohn's disease	0.000179	0.000884	CcSEcCtD
Doxorubicin—Dry skin—Prednisone—Crohn's disease	0.000178	0.000878	CcSEcCtD
Doxorubicin—Shock—Mesalazine—Crohn's disease	0.000177	0.000876	CcSEcCtD
Doxorubicin—Nervous system disorder—Mesalazine—Crohn's disease	0.000176	0.000873	CcSEcCtD
Doxorubicin—Hypokalaemia—Prednisone—Crohn's disease	0.000176	0.000872	CcSEcCtD
Doxorubicin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000176	0.000871	CcSEcCtD
Doxorubicin—Tachycardia—Mesalazine—Crohn's disease	0.000176	0.000869	CcSEcCtD
Doxorubicin—Skin disorder—Mesalazine—Crohn's disease	0.000175	0.000864	CcSEcCtD
Doxorubicin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000174	0.00086	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.000172	0.0523	CbGdCrCtD
Doxorubicin—Anorexia—Mesalazine—Crohn's disease	0.000172	0.000848	CcSEcCtD
Doxorubicin—Muscular weakness—Prednisone—Crohn's disease	0.000171	0.000845	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000171	0.000845	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000171	0.000843	CcSEcCtD
Doxorubicin—ABCB1—lymphoid tissue—Crohn's disease	0.00017	0.00122	CbGeAlD
Doxorubicin—Abdominal distension—Prednisone—Crohn's disease	0.000169	0.000834	CcSEcCtD
Doxorubicin—Hypotension—Mesalazine—Crohn's disease	0.000168	0.000832	CcSEcCtD
Doxorubicin—ABCB1—digestive system—Crohn's disease	0.000168	0.00121	CbGeAlD
Doxorubicin—Pancreatitis—Prednisone—Crohn's disease	0.000164	0.000812	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000164	0.000811	CcSEcCtD
Doxorubicin—Feeling abnormal—Azathioprine—Crohn's disease	0.000163	0.000805	CcSEcCtD
Doxorubicin—Insomnia—Mesalazine—Crohn's disease	0.000163	0.000805	CcSEcCtD
Doxorubicin—Paraesthesia—Mesalazine—Crohn's disease	0.000162	0.000799	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000162	0.000799	CcSEcCtD
Doxorubicin—Dyspnoea—Mesalazine—Crohn's disease	0.00016	0.000793	CcSEcCtD
Doxorubicin—Somnolence—Mesalazine—Crohn's disease	0.00016	0.000791	CcSEcCtD
Doxorubicin—Dyspepsia—Mesalazine—Crohn's disease	0.000158	0.000783	CcSEcCtD
Doxorubicin—Neutropenia—Prednisone—Crohn's disease	0.000157	0.000774	CcSEcCtD
Doxorubicin—Decreased appetite—Mesalazine—Crohn's disease	0.000156	0.000774	CcSEcCtD
Doxorubicin—Body temperature increased—Azathioprine—Crohn's disease	0.000156	0.000772	CcSEcCtD
Doxorubicin—Abdominal pain—Azathioprine—Crohn's disease	0.000156	0.000772	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000155	0.000768	CcSEcCtD
Doxorubicin—Fatigue—Mesalazine—Crohn's disease	0.000155	0.000767	CcSEcCtD
Doxorubicin—Constipation—Mesalazine—Crohn's disease	0.000154	0.000761	CcSEcCtD
Doxorubicin—Pain—Mesalazine—Crohn's disease	0.000154	0.000761	CcSEcCtD
Doxorubicin—Weight increased—Prednisone—Crohn's disease	0.000152	0.000754	CcSEcCtD
Doxorubicin—Weight decreased—Prednisone—Crohn's disease	0.000151	0.000749	CcSEcCtD
Doxorubicin—Hyperglycaemia—Prednisone—Crohn's disease	0.000151	0.000747	CcSEcCtD
Doxorubicin—Feeling abnormal—Mesalazine—Crohn's disease	0.000148	0.000733	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000147	0.000728	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000146	0.000724	CcSEcCtD
Doxorubicin—Hypersensitivity—Azathioprine—Crohn's disease	0.000146	0.00072	CcSEcCtD
Doxorubicin—Urticaria—Mesalazine—Crohn's disease	0.000143	0.000707	CcSEcCtD
Doxorubicin—Abdominal pain—Mesalazine—Crohn's disease	0.000142	0.000703	CcSEcCtD
Doxorubicin—Body temperature increased—Mesalazine—Crohn's disease	0.000142	0.000703	CcSEcCtD
Doxorubicin—Bradycardia—Prednisone—Crohn's disease	0.000136	0.000675	CcSEcCtD
Doxorubicin—Diarrhoea—Azathioprine—Crohn's disease	0.000135	0.000668	CcSEcCtD
Doxorubicin—Haemoglobin—Prednisone—Crohn's disease	0.000135	0.000666	CcSEcCtD
Doxorubicin—Haemorrhage—Prednisone—Crohn's disease	0.000134	0.000663	CcSEcCtD
Doxorubicin—Hypersensitivity—Mesalazine—Crohn's disease	0.000133	0.000656	CcSEcCtD
Doxorubicin—Connective tissue disorder—Prednisone—Crohn's disease	0.000132	0.000651	CcSEcCtD
Doxorubicin—Dizziness—Azathioprine—Crohn's disease	0.000131	0.000646	CcSEcCtD
Doxorubicin—Asthenia—Mesalazine—Crohn's disease	0.000129	0.000638	CcSEcCtD
Doxorubicin—Pruritus—Mesalazine—Crohn's disease	0.000127	0.00063	CcSEcCtD
Doxorubicin—Vomiting—Azathioprine—Crohn's disease	0.000126	0.000621	CcSEcCtD
Doxorubicin—Eye disorder—Prednisone—Crohn's disease	0.000125	0.000619	CcSEcCtD
Doxorubicin—Rash—Azathioprine—Crohn's disease	0.000125	0.000616	CcSEcCtD
Doxorubicin—Dermatitis—Azathioprine—Crohn's disease	0.000124	0.000615	CcSEcCtD
Doxorubicin—Flushing—Prednisone—Crohn's disease	0.000124	0.000615	CcSEcCtD
Doxorubicin—Headache—Azathioprine—Crohn's disease	0.000124	0.000612	CcSEcCtD
Doxorubicin—Diarrhoea—Mesalazine—Crohn's disease	0.000123	0.000609	CcSEcCtD
Doxorubicin—Angiopathy—Prednisone—Crohn's disease	0.000122	0.000601	CcSEcCtD
Doxorubicin—Immune system disorder—Prednisone—Crohn's disease	0.000121	0.000599	CcSEcCtD
Doxorubicin—Arrhythmia—Prednisone—Crohn's disease	0.00012	0.000592	CcSEcCtD
Doxorubicin—Dizziness—Mesalazine—Crohn's disease	0.000119	0.000588	CcSEcCtD
Doxorubicin—Alopecia—Prednisone—Crohn's disease	0.000118	0.000586	CcSEcCtD
Doxorubicin—Mental disorder—Prednisone—Crohn's disease	0.000117	0.000581	CcSEcCtD
Doxorubicin—Nausea—Azathioprine—Crohn's disease	0.000117	0.00058	CcSEcCtD
Doxorubicin—Erythema—Prednisone—Crohn's disease	0.000117	0.000577	CcSEcCtD
Doxorubicin—Malnutrition—Prednisone—Crohn's disease	0.000117	0.000577	CcSEcCtD
Doxorubicin—Vomiting—Mesalazine—Crohn's disease	0.000114	0.000566	CcSEcCtD
Doxorubicin—Rash—Mesalazine—Crohn's disease	0.000113	0.000561	CcSEcCtD
Doxorubicin—Dermatitis—Mesalazine—Crohn's disease	0.000113	0.000561	CcSEcCtD
Doxorubicin—Headache—Mesalazine—Crohn's disease	0.000113	0.000557	CcSEcCtD
Doxorubicin—Vision blurred—Prednisone—Crohn's disease	0.00011	0.000544	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—Crohn's disease	0.000108	0.000535	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—Crohn's disease	0.000108	0.000533	CcSEcCtD
Doxorubicin—Agitation—Prednisone—Crohn's disease	0.000107	0.00053	CcSEcCtD
Doxorubicin—Nausea—Mesalazine—Crohn's disease	0.000107	0.000529	CcSEcCtD
Doxorubicin—Malaise—Prednisone—Crohn's disease	0.000105	0.00052	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—Crohn's disease	0.000105	0.000518	CcSEcCtD
Doxorubicin—Syncope—Prednisone—Crohn's disease	0.000105	0.000517	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—Crohn's disease	0.000103	0.000507	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—Crohn's disease	0.000101	0.0005	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—Crohn's disease	0.000101	0.000498	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—Crohn's disease	9.93e-05	0.000491	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—Crohn's disease	9.93e-05	0.000491	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—Crohn's disease	9.9e-05	0.000489	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	9.86e-05	0.000488	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—Crohn's disease	9.81e-05	0.000485	CcSEcCtD
Doxorubicin—ABCB1—lymph node—Crohn's disease	9.58e-05	0.000689	CbGeAlD
Doxorubicin—Anaphylactic shock—Prednisone—Crohn's disease	9.52e-05	0.000471	CcSEcCtD
Doxorubicin—Oedema—Prednisone—Crohn's disease	9.52e-05	0.000471	CcSEcCtD
Doxorubicin—Infection—Prednisone—Crohn's disease	9.46e-05	0.000468	CcSEcCtD
Doxorubicin—Shock—Prednisone—Crohn's disease	9.37e-05	0.000463	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—Crohn's disease	9.34e-05	0.000462	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—Crohn's disease	9.29e-05	0.00046	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—Crohn's disease	9.25e-05	0.000457	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—Crohn's disease	9.2e-05	0.000455	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—Crohn's disease	9.08e-05	0.000449	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—Crohn's disease	8.67e-05	0.000429	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—Crohn's disease	8.61e-05	0.000426	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—Crohn's disease	8.55e-05	0.000423	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—Crohn's disease	8.38e-05	0.000414	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—Crohn's disease	8.28e-05	0.000409	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—Crohn's disease	8.21e-05	0.000406	CcSEcCtD
Doxorubicin—Constipation—Prednisone—Crohn's disease	8.14e-05	0.000403	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—Crohn's disease	7.85e-05	0.000388	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—Crohn's disease	7.79e-05	0.000385	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—Crohn's disease	7.56e-05	0.000374	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—Crohn's disease	7.53e-05	0.000372	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—Crohn's disease	7.53e-05	0.000372	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—Crohn's disease	7.01e-05	0.000347	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—Crohn's disease	6.83e-05	0.000338	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—Crohn's disease	6.74e-05	0.000333	CcSEcCtD
Doxorubicin—Diarrhoea—Prednisone—Crohn's disease	6.51e-05	0.000322	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—Crohn's disease	6.3e-05	0.000311	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—Crohn's disease	6.05e-05	0.000299	CcSEcCtD
Doxorubicin—Rash—Prednisone—Crohn's disease	6e-05	0.000297	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—Crohn's disease	6e-05	0.000297	CcSEcCtD
Doxorubicin—Headache—Prednisone—Crohn's disease	5.96e-05	0.000295	CcSEcCtD
Doxorubicin—Nausea—Prednisone—Crohn's disease	5.66e-05	0.00028	CcSEcCtD
Doxorubicin—NQO1—Metabolism—FADS1—Crohn's disease	5.24e-05	0.000387	CbGpPWpGaD
Doxorubicin—NOS1—Disease—UBE2D1—Crohn's disease	5.24e-05	0.000386	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PLA2G4F—Crohn's disease	5.23e-05	0.000386	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RBX1—Crohn's disease	5.23e-05	0.000386	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—ALB—Crohn's disease	5.18e-05	0.000382	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	5.15e-05	0.00038	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.1e-05	0.000376	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTGER4—Crohn's disease	5.09e-05	0.000375	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.09e-05	0.000375	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.08e-05	0.000374	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—FADS1—Crohn's disease	5.06e-05	0.000373	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.03e-05	0.000371	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PLA2G4F—Crohn's disease	5.02e-05	0.00037	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	5.01e-05	0.00037	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GPX4—Crohn's disease	4.91e-05	0.000362	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR9—Crohn's disease	4.84e-05	0.000357	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SLC11A1—Crohn's disease	4.83e-05	0.000356	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—JAK2—Crohn's disease	4.82e-05	0.000355	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GCKR—Crohn's disease	4.74e-05	0.00035	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GPX4—Crohn's disease	4.74e-05	0.000349	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—IL6—Crohn's disease	4.73e-05	0.000349	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RSPO3—Crohn's disease	4.72e-05	0.000348	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—FADS1—Crohn's disease	4.7e-05	0.000347	CbGpPWpGaD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	4.69e-05	0.000346	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.67e-05	0.000344	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GCKR—Crohn's disease	4.62e-05	0.00034	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—UBE2D1—Crohn's disease	4.59e-05	0.000338	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GCKR—Crohn's disease	4.58e-05	0.000337	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RBX1—Crohn's disease	4.51e-05	0.000332	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HSPA1B—Crohn's disease	4.51e-05	0.000332	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GPR65—Crohn's disease	4.5e-05	0.000332	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.5e-05	0.000332	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SEL1L—Crohn's disease	4.47e-05	0.00033	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTMR3—Crohn's disease	4.45e-05	0.000328	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RIPK2—Crohn's disease	4.45e-05	0.000328	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.45e-05	0.000328	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.43e-05	0.000326	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GPX4—Crohn's disease	4.4e-05	0.000325	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL3—Crohn's disease	4.34e-05	0.00032	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—FADS1—Crohn's disease	4.28e-05	0.000315	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTMR3—Crohn's disease	4.27e-05	0.000315	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GCKR—Crohn's disease	4.25e-05	0.000314	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2RA—Crohn's disease	4.2e-05	0.000309	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RASGRP1—Crohn's disease	4.2e-05	0.000309	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RBX1—Crohn's disease	4.14e-05	0.000305	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HSPA1B—Crohn's disease	4.14e-05	0.000305	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	4.12e-05	0.000304	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RSPO3—Crohn's disease	4.1e-05	0.000303	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR9—Crohn's disease	4.09e-05	0.000301	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SLC11A1—Crohn's disease	4.08e-05	0.000301	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GPX4—Crohn's disease	4e-05	0.000295	CbGpPWpGaD
Doxorubicin—NOS2—Disease—UBE2D1—Crohn's disease	3.95e-05	0.000291	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PLA2G4F—Crohn's disease	3.93e-05	0.00029	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.91e-05	0.000288	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—ALB—Crohn's disease	3.91e-05	0.000288	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—IL6—Crohn's disease	3.9e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SEL1L—Crohn's disease	3.89e-05	0.000287	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GCKR—Crohn's disease	3.87e-05	0.000285	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PLA2G4F—Crohn's disease	3.8e-05	0.00028	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SOCS1—Crohn's disease	3.8e-05	0.00028	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GPR65—Crohn's disease	3.8e-05	0.00028	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.79e-05	0.000279	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SMAD3—Crohn's disease	3.75e-05	0.000276	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	3.73e-05	0.000275	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—JAK2—Crohn's disease	3.63e-05	0.000268	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—UBE2D1—Crohn's disease	3.63e-05	0.000268	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	3.55e-05	0.000261	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RBX1—Crohn's disease	3.5e-05	0.000258	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HSPA1B—Crohn's disease	3.5e-05	0.000258	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LTF—Crohn's disease	3.49e-05	0.000257	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—ALB—Crohn's disease	3.47e-05	0.000256	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—FADS1—Crohn's disease	3.47e-05	0.000256	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—ALB—Crohn's disease	3.47e-05	0.000256	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLA2G4F—Crohn's disease	3.46e-05	0.000255	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.44e-05	0.000254	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.4e-05	0.00025	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.4e-05	0.00025	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTMR3—Crohn's disease	3.34e-05	0.000246	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—FADS1—Crohn's disease	3.32e-05	0.000245	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	3.3e-05	0.000243	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SMAD3—Crohn's disease	3.28e-05	0.000242	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.27e-05	0.000241	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ALB—Crohn's disease	3.26e-05	0.00024	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GPX4—Crohn's disease	3.25e-05	0.000239	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTMR3—Crohn's disease	3.23e-05	0.000238	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR6—Crohn's disease	3.21e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	3.16e-05	0.000233	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GCKR—Crohn's disease	3.14e-05	0.000231	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX4—Crohn's disease	3.11e-05	0.000229	CbGpPWpGaD
Doxorubicin—NOS3—Disease—UBE2D1—Crohn's disease	3.07e-05	0.000226	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2RA—Crohn's disease	3.04e-05	0.000224	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ALB—Crohn's disease	3.03e-05	0.000224	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTGS2—Crohn's disease	3.03e-05	0.000224	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTGS2—Crohn's disease	3.03e-05	0.000224	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GCKR—Crohn's disease	3.01e-05	0.000222	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTMR3—Crohn's disease	2.94e-05	0.000217	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RBX1—Crohn's disease	2.9e-05	0.000214	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.86e-05	0.000211	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGS2—Crohn's disease	2.85e-05	0.00021	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SMAD3—Crohn's disease	2.83e-05	0.000208	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTGER4—Crohn's disease	2.82e-05	0.000208	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—JAK2—Crohn's disease	2.82e-05	0.000208	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GCKR—Crohn's disease	2.81e-05	0.000207	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ALB—Crohn's disease	2.77e-05	0.000204	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR6—Crohn's disease	2.71e-05	0.0002	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	2.67e-05	0.000196	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—FADS1—Crohn's disease	2.61e-05	0.000192	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SMAD3—Crohn's disease	2.6e-05	0.000191	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—Crohn's disease	2.59e-05	0.000191	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—UBE2D1—Crohn's disease	2.54e-05	0.000187	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	2.54e-05	0.000187	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—FADS1—Crohn's disease	2.52e-05	0.000186	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC11A1—Crohn's disease	2.49e-05	0.000183	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RIPK2—Crohn's disease	2.47e-05	0.000182	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RBX1—Crohn's disease	2.45e-05	0.000181	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TYK2—Crohn's disease	2.44e-05	0.00018	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX4—Crohn's disease	2.44e-05	0.00018	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—Crohn's disease	2.43e-05	0.000179	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL3—Crohn's disease	2.4e-05	0.000177	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.39e-05	0.000176	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTGER4—Crohn's disease	2.39e-05	0.000176	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX4—Crohn's disease	2.36e-05	0.000174	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GCKR—Crohn's disease	2.36e-05	0.000174	CbGpPWpGaD
Doxorubicin—NOS1—Disease—JAK2—Crohn's disease	2.33e-05	0.000172	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RASGRP1—Crohn's disease	2.33e-05	0.000171	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—Crohn's disease	2.3e-05	0.000169	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—FADS1—Crohn's disease	2.29e-05	0.000169	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GCKR—Crohn's disease	2.28e-05	0.000168	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—Crohn's disease	2.26e-05	0.000167	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.24e-05	0.000165	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—Crohn's disease	2.21e-05	0.000163	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—Crohn's disease	2.19e-05	0.000162	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SMAD3—Crohn's disease	2.19e-05	0.000162	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTMR3—Crohn's disease	2.16e-05	0.000159	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.15e-05	0.000158	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—UBE2D1—Crohn's disease	2.15e-05	0.000158	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX4—Crohn's disease	2.15e-05	0.000158	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TYK2—Crohn's disease	2.14e-05	0.000158	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RBX1—Crohn's disease	2.13e-05	0.000157	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HSPA1B—Crohn's disease	2.13e-05	0.000157	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.12e-05	0.000156	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SOCS1—Crohn's disease	2.11e-05	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RIPK2—Crohn's disease	2.08e-05	0.000154	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GCKR—Crohn's disease	2.07e-05	0.000153	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.04e-05	0.000151	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—JAK2—Crohn's disease	2.04e-05	0.000151	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL3—Crohn's disease	2.03e-05	0.00015	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RASGRP1—Crohn's disease	1.96e-05	0.000145	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.96e-05	0.000145	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.88e-05	0.000139	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.87e-05	0.000138	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—UBE2D1—Crohn's disease	1.87e-05	0.000138	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—Crohn's disease	1.86e-05	0.000137	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TYK2—Crohn's disease	1.84e-05	0.000136	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SMAD3—Crohn's disease	1.82e-05	0.000134	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SOCS1—Crohn's disease	1.78e-05	0.000131	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.76e-05	0.00013	CbGpPWpGaD
Doxorubicin—NOS2—Disease—JAK2—Crohn's disease	1.76e-05	0.00013	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—Crohn's disease	1.71e-05	0.000126	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TYK2—Crohn's disease	1.69e-05	0.000125	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2RA—Crohn's disease	1.68e-05	0.000124	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.68e-05	0.000124	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—FADS1—Crohn's disease	1.68e-05	0.000124	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.68e-05	0.000124	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—Crohn's disease	1.67e-05	0.000123	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—Crohn's disease	1.66e-05	0.000122	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.63e-05	0.00012	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.62e-05	0.000119	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—JAK2—Crohn's disease	1.62e-05	0.000119	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.6e-05	0.000118	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTMR3—Crohn's disease	1.59e-05	0.000117	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX4—Crohn's disease	1.57e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SMAD3—Crohn's disease	1.54e-05	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—Crohn's disease	1.53e-05	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—Crohn's disease	1.52e-05	0.000112	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GCKR—Crohn's disease	1.52e-05	0.000112	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—Crohn's disease	1.51e-05	0.000111	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—Crohn's disease	1.5e-05	0.000111	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.5e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.47e-05	0.000109	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—Crohn's disease	1.46e-05	0.000107	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TYK2—Crohn's disease	1.43e-05	0.000106	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.42e-05	0.000105	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2RA—Crohn's disease	1.42e-05	0.000105	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.41e-05	0.000104	CbGpPWpGaD
Doxorubicin—NOS3—Disease—JAK2—Crohn's disease	1.37e-05	0.000101	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—Crohn's disease	1.35e-05	9.98e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SMAD3—Crohn's disease	1.34e-05	9.86e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—Crohn's disease	1.32e-05	9.73e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—Crohn's disease	1.29e-05	9.54e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—Crohn's disease	1.29e-05	9.52e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—Crohn's disease	1.29e-05	9.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—Crohn's disease	1.27e-05	9.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—FADS1—Crohn's disease	1.24e-05	9.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—Crohn's disease	1.23e-05	9.07e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—Crohn's disease	1.2e-05	8.81e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TYK2—Crohn's disease	1.19e-05	8.75e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—Crohn's disease	1.19e-05	8.75e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—Crohn's disease	1.18e-05	8.73e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—FADS1—Crohn's disease	1.17e-05	8.61e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX4—Crohn's disease	1.16e-05	8.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.15e-05	8.5e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.13e-05	8.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JAK2—Crohn's disease	1.13e-05	8.34e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCKR—Crohn's disease	1.12e-05	8.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX4—Crohn's disease	1.09e-05	8.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—Crohn's disease	1.08e-05	7.93e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCKR—Crohn's disease	1.06e-05	7.78e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—Crohn's disease	1.05e-05	7.72e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—Crohn's disease	1.03e-05	7.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TYK2—Crohn's disease	1e-05	7.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—Crohn's disease	1e-05	7.39e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—Crohn's disease	9.98e-06	7.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTMR3—Crohn's disease	9.8e-06	7.22e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—Crohn's disease	9.57e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JAK2—Crohn's disease	9.57e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—Crohn's disease	9.02e-06	6.65e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—Crohn's disease	8.73e-06	6.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—Crohn's disease	8.73e-06	6.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TYK2—Crohn's disease	8.72e-06	6.43e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—Crohn's disease	8.37e-06	6.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAK2—Crohn's disease	8.32e-06	6.13e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—Crohn's disease	8.31e-06	6.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—Crohn's disease	8.29e-06	6.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—Crohn's disease	7.89e-06	5.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—Crohn's disease	7.83e-06	5.77e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FADS1—Crohn's disease	7.64e-06	5.63e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	7.62e-06	5.61e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—Crohn's disease	7.5e-06	5.53e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—Crohn's disease	7.25e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX4—Crohn's disease	7.15e-06	5.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—Crohn's disease	7.02e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—Crohn's disease	7e-06	5.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCKR—Crohn's disease	6.91e-06	5.09e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—Crohn's disease	6.6e-06	4.86e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—Crohn's disease	6.56e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—Crohn's disease	6.34e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—Crohn's disease	6.11e-06	4.5e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—Crohn's disease	5.8e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—Crohn's disease	5.77e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—Crohn's disease	4.9e-06	3.61e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—Crohn's disease	4.84e-06	3.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—Crohn's disease	4.27e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—Crohn's disease	4.23e-06	3.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—Crohn's disease	3.57e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—Crohn's disease	3.36e-06	2.48e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—Crohn's disease	3.12e-06	2.3e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.94e-06	2.17e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—Crohn's disease	2.2e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.92e-06	1.42e-05	CbGpPWpGaD
